Cite
MLA Citation
Martin Tom et al.. “RTHP-20. MULTI-INSTITUTIONAL ANALYSIS OF HIGH-RISK WHO GRADE II OLIGODENDROGLIOMA TREATED WITH ADJUVANT RADIOTHERAPY PLUS TEMOZOLOMIDE (TMZ) VERSUS PROCARBAZINE, LOMUSTINE, AND VINCRISTINE (PCV).” Neuro-oncology, vol. 21, n.d., pp. vi213–vi214. http://access.bl.uk/ark:/81055/vdc_100101669015.0x000038